Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Camero or

<< Previous

Bullboard Posts

Next >>

Comment by CamaroZL1on Feb 01, 2021 7:30pm

88 Views

Post# 32442196

RE:RE:RE:Camero or

These stocks are still something like 30 and 40% short. You are excluding longs booking profit, new longs and new shorts. once the trend exhausts then the entire market can turn seller. flash crash with no bid, the only buyers would be new shorts unmotivated to cover.

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network